RIPK1 and osteosarcoma: The K-HOS shRIPK1-1 cell line, which showed the highest inhibition of RIPK1 expression and a significant blockade of the TRAIL non-apoptotic pathways activation following AMG655 treatment, was selected for the induction of para-tibial orthotopic osteosarcoma in nude mice.